CSF3 and breast cancer: In murine breast cancer models, treatment with doxycycline was associated with reduced plasma levels of pro-inflammatory cytokines such as IL-1β, IL-6, IL-9, VEGF, and granulocyte colony-stimulating factor (G-CSF) [90].